Patents by Inventor Ludovic T. Maillard

Ludovic T. Maillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS THAT ARE LIGANDS FOR G-PROTEIN-COUPLED RECEPTORS (GPCRS) AND ARE MODULATORS OF TRANSCRIPTION FACTORS AND COACTIVATORS
    Publication number: 20170369523
    Abstract: Template-fixed ?-hairpin peptidomimetics of the general formula wherein Z is a template-fixed chain of 8 ?-amino acid residues which, depending on their positions in the chain (counted starting from the N-terminal amino acid), are Gly or Pro or of certain types which, as the remaining symbols in the above formula, are defined in the description and the claims, and salts thereof, have agonizing or antagonizing activity against urotensin II or show inhibition of the STAT6/NCoA-1 interaction and can be used for preventing or treating diseases or disorders related to urotensin II, STAT6 and NCoA-1. These ?-hairpin peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    Type: Application
    Filed: September 11, 2017
    Publication date: December 28, 2017
    Applicant: POLYPHOR AG
    Inventors: John Anthony ROBINSON, Kerstin MÖHLE, Markus SEITZ, Ludovic T. MAILLARD, Roba MOUNME, Frank Otto GOMBERT, Odile SELLIER-KESSLER, Heiko HENZE, Daniel OBRECHT, Christian BISANG, Alexander LEDERER
  • TEMPLATE-FIXED PEPTIDOMIMETICS
    Publication number: 20110230426
    Abstract: Template-fixed ?-hairpin peptidomimetics of the general formula wherein Z is a template-fixed chain of 8 ?-amino acid residues which, depending on their positions in the chain (counted starting from the N-terminal amino acid), are Gly or Pro or of certain types which, as the remaining symbols in the above formula, are defined in the description and the claims, and salts thereof, have agonizing or antagonizing activity against urotensin II or show inhibition of the STAT6/NCoA-1 interaction and can be used for preventing or treating diseases or disorders related to urotensin II, STAT6 and NCoA-1. These ?-hairpin peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    Type: Application
    Filed: August 8, 2008
    Publication date: September 22, 2011
    Applicants: POLYPHOR AG, UNIVERSITAT ZURICH
    Inventors: Daniel Obrecht, Frank Gombert, Markus Seitz, Ludovic T. Maillard, Roba Mounme, Kerstin Moehle, John Anthony Robinson, Odile Sellier-Kessler, Heiko Henze, Christian Bisang, Alexander Lederer